Dr Cali Bartholomeusz completed her Honours and PhD at the Brain Sciences Institute, Swinburne University in 2008. Her thesis investigated the effects of estrogen treatment on cognition in healthy young women and women with chronic schizophrenia, and whether effects were related to estrogen’s interaction with the cholinergic neurotransmitter system. Dr Bartholomeusz later received an NHMRC Postdoctoral fellowship (2009-2012) to investigate whether social cognitive deficits are related to structural and functional brain abnormalities in young people with an emerging psychotic illness.
Dr Bartholomeusz’s broader research focuses on (1) characterizing abnormalities in ‘social brain’ regions during adolescence and whether these are specific risk factors for development of a psychotic disorder; (2) development and evaluation of new interventions for the treatment of cognitive deficits and poor social functioning in the early phase of psychosis and related disorders; and (3) to advocate for the amalgamation of basic neuroscience techniques and clinical outcomes research. She is also the Co-Chair of the Psychosis and Developmental Neuropsychiatry Group and is a board member of the Mental Health Research and Ethics Committee at Melbourne Health.